Avidity Biosciences, Inc. (NASDAQ:RNA) is one of the Best Stocks to Buy for the Next 3 Months According to Hedge Funds. On September 3, Eric Schmidt FCA from Cantor Fitzgerald reiterated a Buy rating on Avidity Biosciences, Inc. (NASDAQ:RNA) with a price target of $96. The reiterated Buy rating on the stock comes after the company reported strong business updates in its fiscal second quarter of 2025. The company reported progress in three late-stage neuromuscular programs for treating Duchenne muscular dy ...